Regorafenib (Stivarga) - Oncology Nurse Advisor
Skip to navigation Skip to main content

Regorafenib (Stivarga)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow examines regorafenib (Stivarga), indicated for the treatment of patients with metastatic colorectal cancer (CRC) or metastatic gastrointestinal stromal tumor (GIST) .

Table of Contents

Slide 4: Indication, Dosage, and Administration
Slide 11: Cautions, Effects, and Interactions
Slide 18: What to Tell Your Patient
Slide 27: References

 

Topics:

Colorectal Cancer Gastrointestinal Cancer Slideshows Stat Consult